Pay hike for top bosses and board members at big Danish companies

Senior managers at blue chip C20 companies earn on average 12.6 million kroner

According to a study by the accountancy firm PwC, bosses and board members at big Danish companies have received a significant pay rise this year, Jyllands-Posten reports.

This year the average remuneration for board members at the blue chip C20 companies increased by 8 percent to 628,000 kroner.

“Besides just one company, all of them have either maintained or increased their remuneration,” the report stated.

What’s more, at those companies where the chairman’s remuneration was reported separately, it was three times as much as other board members: 1.28 million kroner on average.

Meanwhile, members of the senior management team at C20 companies picked up on average 10 percent more than last year, with an average remuneration of 12.6 million kroner.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.